Mike Segar/Reuters
- Johnson & Johnson beat on both the top and bottom lines.
- The healthcare conglomerate cut its full-year adjusted earnings and sales forecasts.
- Watch Johnson & Johnson trade in real time here.
(Reuters) - Johnson & Johnson lowered its sales forecast for 2018 on Tuesday, citing a strengthening dollar.
Shares of the Dow component fell 1 percent to $123.45 in premarket trading. They have dropped 10.7 percent this year.
See the rest of the story at Business Insider
NOW WATCH: Here's why the US Men's team sucks at soccer
See Also:
- UnitedHealth raises its full-year earnings forecast
- I've taken AncestryDNA, 23andMe, and National Geographic genetics tests — here's how to choose one to try
- Wells Fargo misses as loans fall and expenses rise
from Business Insider https://ift.tt/2LriC8O
No comments:
Post a Comment